The addictive qualities of the powerful pain drug OxyContin have made it controversial, but the FDA has now approved it for youth 11 to 16 after asking maker Purdue Pharma to study its use in that age group. In a post on Thursday, the FDA's Sharon Hertz, director of the Division of Anesthesia, Analgesia, and Addiction Products, wrote that without solid data, doctors too often have to control pediatric pain from cancer and other traumas, by relying "on their own experience to interpret and translate adult data into dosing information for pediatric patients." It will not be the first go-to product but in cases where it is needed, she said doctors now have the info needed to move away from educated guesses. Post | More